...
首页> 外文期刊>Clinical Chemistry: Journal of the American Association for Clinical Chemists >Three-Dimensional Microarray Compared with PCR–Single-Strand Conformation Polymorphism Analysis/DNA Sequencing for Mutation Analysis of K-ras Codons 12 and 13
【24h】

Three-Dimensional Microarray Compared with PCR–Single-Strand Conformation Polymorphism Analysis/DNA Sequencing for Mutation Analysis of K-ras Codons 12 and 13

机译:三维微阵列与PCR-单链构象多态性分析/ DNA序列比较对K-ras密码子12和13的突变分析

获取原文

摘要

Background: We developed a rapid, precise, and accurate microarray-based method that uses a three-dimensional platform for detection of mutations.Methods: We used the PamChip? microarray to detect mutations in codons 12 and 13 of K- ras in 15 cell lines and 81 gastric or colorectal cancer tissues. Fluorescein isothiocyanate-labeled PCR products were analyzed with the microarray. We confirmed the microarray results with PCR–single-strand conformation polymorphism (SSCP) analysis and DNA sequencing.Results: We could correctly identify wild-type, heterozygous, and homozygous mutant genotypes with the PamChip microarray in 3.5 h. The array data were consistent with those of PCR-SSCP analysis and DNA sequencing. All 15 cell lines and 80 of 81 clinical cancer specimens (98.8%; 95% confidence interval, 96.4–100%) were genotyped accurately with the microarray, a rate better than that of direct DNA sequencing (38.9%) or SSCP (93.8%). Only one clinical specimen was misdiagnosed as homozygous for the wild-type allele. Densitometric analysis of SSCP bands indicated that the content of the mutant allele in the specimen was ~16%. The PamChip microarray could detect mutant alleles representing more than 25% of the SSCP band proportions. Therefore, the limit for detection of mutant alleles by the PamChip microarray was estimated to be 16–25% of the total DNA.Conclusions: The PamChip microarray is a novel three-dimensional microarray system and can be used to analyze K- ras mutations quickly and accurately. The mutation detection rate was nearly 100% and was similar to that of PCR-SSCP together with sequencing analysis, but the microarray analysis was faster and easier.
机译:背景:我们开发了一种快速,精确,准确的基于微阵列的方法,该方法使用三维平台检测突变。方法:我们使用了PamChip?芯片检测15种细胞系和81种胃癌或结直肠癌组织中K-ras密码子12和13的突变。用微阵列分析异硫氰酸荧光素标记的PCR产物。我们通过PCR单链构象多态性(SSCP)分析和DNA测序证实了微阵列的结果。结果:我们可以在<3.5 h内用PamChip微阵列正确鉴定野生型,杂合型和纯合型突变基因型。阵列数据与PCR-SSCP分析和DNA测序一致。使用微阵列芯片对所有15种细胞系和81种临床癌症标本中的80种(98.8%; 95%置信区间,96.4–100%)进行了准确的基因分型,其比率优于直接DNA测序(38.9%)或SSCP(93.8%)的比率。 )。仅一个临床标本被误诊为野生型等位基因纯合子。 SSCP条带的光密度分析表明,标本中突变等位基因的含量为〜16%。 PamChip微阵列可以检测到代表SSCP谱带比例超过25%的突变等位基因。因此,据估计,PamChip芯片检测突变等位基因的限制为总DNA的16–25%。结论:PamChip芯片是一种新型的三维芯片系统,可用于快速分析K-ras突变准确地。突变检测率接近100%,与PCR-SSCP和测序分析相似,但微阵列分析更快,更容易。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号